Literature DB >> 3646869

Inactivation of human T-lymphotropic virus type III/lymphadenopathy-associated virus by formaldehyde-based reagents.

L S Martin, S L Loskoski, J S McDougal.   

Abstract

Neutral buffered Formalin, a fixative used in most pathology laboratories, was found to inactivate human T-lymphotropic virus type III/lymphadenopathy-associated virus. Preparations containing this virus with infectivity titers of greater than 10(5) were treated with 1% or greater neutral buffered Formalin; after treatment, virus was undetectable (titer, less than 10(1)). In addition, when infected phytohemagglutinin-stimulated lymphocytes were treated with paraformaldehyde, transmission of the virus to other such lymphocytes was eliminated.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3646869      PMCID： PMC203741          DOI： 10.1128/aem.53.4.708-709.1987

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  4 in total

1.  Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

Authors:  J S McDougal; S P Cort; M S Kennedy; C D Cabridilla; P M Feorino; D P Francis; D Hicks; V S Kalyanaraman; L S Martin
Journal:  J Immunol Methods       Date:  1985-01-21       Impact factor: 2.303

2.  Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus.

Authors:  L S Martin; J S McDougal; S L Loskoski
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

3.  Inactivation of lymphadenopathy associated virus by chemical disinfectants.

Authors:  B Spire; F Barré-Sinoussi; L Montagnier; J C Chermann
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

4.  Quantitative assays for evaluation of HTLV-III inactivation procedures: tri(N-butyl)phosphate:sodium cholate and beta-propiolactone.

Authors:  A M Prince; B Horowitz; H Dichtelmueller; W Stephan; R C Gallo
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701
  4 in total
  6 in total

1.  Evaluation of semiautomated procedure for lymphocyte subset analysis.

Authors:  G J Bryson; R P Keegan; C P Quinn; R J Collins
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

Review 2.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

3.  Fixation of cryo-sections under HIV-1 inactivating conditions: integrity of antigen binding sites and cell surface antigens.

Authors:  J D Laman; N Kors; J L Heeney; W J Boersma; E Claassen
Journal:  Histochemistry       Date:  1991

4.  Prevention of contamination by xenotropic murine leukemia virus-related virus: susceptibility to alcohol-based disinfectants and environmental stability.

Authors:  David Palesch; Mohammad Khalid; Christina M Stürzel; Jan Münch
Journal:  Appl Environ Microbiol       Date:  2014-02-14       Impact factor: 4.792

5.  Ultraviolet germicidal irradiation and its effects on elemental distributions in mouse embryonic fibroblast cells in x-ray fluorescence microanalysis.

Authors:  Qiaoling Jin; Stefan Vogt; Barry Lai; Si Chen; Lydia Finney; Sophie-Charlotte Gleber; Jesse Ward; Junjing Deng; Rachel Mak; Nena Moonier; Chris Jacobsen
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

6.  Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood.

Authors:  David van Bockel; David A Price; Tedi E Asher; Vanessa Venturi; Kazuo Suzuki; Kristina Warton; Miles P Davenport; David A Cooper; Daniel C Douek; Anthony D Kelleher
Journal:  J Immunol Methods       Date:  2007-08-09       Impact factor: 2.303
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.